Breast cancer cell-derived cytokines, macrophages and cell adhesion: Implications for metastasis

Anticancer Research

Volumn 31, Issue 10, 2011, Pages 3219-3227

  Eichbaum, Christine ^a   Meyer, Anne Sophie ^a   Wang, Ni ^b   Bischofs, Esther ^a   Steinborn, Andrea ^a   Bruckner, Thomas ^a   Brodt, Pnina ^b   Sohn, Christof ^a   Eichbaum, Michael H R ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Breast cancer; E selectin; Endothelium; Liver metastasis; Pro inflammatory microenvironment

Indexed keywords

CIMETIDINE; COLONY STIMULATING FACTOR 1; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EPIDERMAL GROWTH FACTOR; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; LYMPHOTOXIN; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; RANTES; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER PREVENTION; CELL ADHESION; CYTOKINE RELEASE; ENDOTHELIUM CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LIVER METASTASIS; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SUPERNATANT; TUMOR CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CIMETIDINE; CYTOKINES; E-SELECTIN; ENDOTHELIAL CELLS; FEMALE; HUMANS; MACROPHAGES; MICE; NEOPLASM METASTASIS; SOLUBILITY; SUBCELLULAR FRACTIONS; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS; UP-REGULATION;

EID: 80054736578     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Nemoto T and Dao TL: Significance of liver metastasis in women with disseminated breast cancer undergoing endocrine ablative surgery. Cancer 19: 421-427, 1966.
2. Viadana E, Bross ID and Pickren JW: An autopsy study of some routes of dissemination of cancer of the breast. Br J Cancer 27: 336-340, 1973.
3. Zinser JW, Hortobagyi GN, Buzdar AU, Smith TL and Fraschini G: Clinical course of breast cancer patients with liver metastases. J Clin Oncol 5: 773-782, 1987. (Pubitemid 17120255)
4. Patanaphan V, Salazar OM and Risco R: Breast cancer: metastatic patterns and their prognosis. South Med J 81: 1109-1112, 1988.
5. Hoe AL, Royle GT and Taylor I: Breast liver metastases-incidence, diagnosis and outcome. J R Soc Med 84: 714-716, 1991.
6. Wyld L, Gutteridge E, Pinder SE, James JJ, Chan SY, Cheung KL, Robertson JF and Evans AJ: Prognostic factors for patients with hepatic metastases from breast cancer. Br J Cancer 89: 284-290, 2003. (Pubitemid 36976317)
7. Eichbaum MH, Kaltwasser M, Bruckner T, de Rossi TM, Schneeweiss A and Sohn C: Prognostic factors for patients with liver metastases from breast cancer. Breast Cancer Res Treat 96: 53-62, 2006.
8. Pritchard KI: Liver metastases: Can our understanding of their biology and prognostic value contribute to a strategy for optimum therapeutic management? Eur J Cancer 33(Suppl 7): S11-14, 1997.
9. Eichbaum MH, de Rossi TM, Kaul S and Bastert G: Serum levels of soluble E-selectin are associated with the clinical course of metastatic disease in patients with liver metastases from breast cancer. Oncol Res 14: 603-610, 2004. (Pubitemid 40178961)
10. Eichbaum MH, de Rossi TM, Kaul S, Bruckner T, Schneeweiss A and Sohn C: Serum levels of hepatocyte growth factor/scatter factor in patients with liver metastases from breast cancer. Tumour Biol 28: 36-44, 2007. (Pubitemid 46012464)
11. Khatib AM, Auguste P, Fallavollita L, Wang N, Samani A, Kontogiannea M, Meterissian S and Brodt P: Characterization of the host proinflammatory response to tumor cells during the initial stages of liver metastasis. Am J Pathol 167: 749-759, 2005. (Pubitemid 41216359)
12. Auguste P, Fallavollita L, Wang N, Burnier J, Bikfalvi A and Brodt P: The host inflammatory response promotes liver metastasis by increasing tumor cell arrest and extravasation. Am J Pathol 170: 1781-1792, 2007. (Pubitemid 47339320)
13. Szlosarek PW and Balkwill FR: Tumour necrosis factor alpha: a potential target for the therapy of solid tumours. Lancet Oncol 4: 565-573, 2003. (Pubitemid 38351714)
14. Sturm JW, Magdeburg R, Berger K, Petruch B, Samel S, Bonninghoff R, Keese M, Hafner M and Post S: Influence of TNFA on the formation of liver metastases in a syngenic mouse model. Int J Cancer 107: 11-21, 2003. (Pubitemid 37100080)
15. Anderson GM, Nakada MT and DeWitte M: Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer. Curr Opin Pharmacol 4: 314-320, 2004. (Pubitemid 38987055)
16. Khatib AM, Kontogiannea M, Fallavollita L, Jamison B, Meterissian S and Brodt P: Rapid induction of cytokine and E-selectin expression in the liver in response to metastatic tumor cells. Cancer Res 59: 1356-1361, 1999. (Pubitemid 29136269)
17. Wang N, Thuraisingam T, Fallavollita L, Ding A, Radzioch D and Brodt P: The secretory leukocyte protease inhibitor is a type 1 insulin-like growth factor receptor-regulated protein that protects against liver metastasis by attenuating the host proinflammatory response. Cancer Res 66: 3062-3070, 2006.
18. Brodt P, Fallavollita L, Bresalier RS, Meterissian S, Norton CR and Wolitzky BA: Liver endothelial E-selectin mediates carcinoma cell adhesion and promotes liver metastasis. Int J Cancer 71: 612-619, 1997. (Pubitemid 27239372)
19. St Hill CA: Interactions between endothelial selectins and cancer cells regulate metastasis. Front Biosci 17: 3233-3251, 2011.
20. Kobayashi H, Boelte KC and Lin PC: Endothelial cell adhesion molecules and cancer progression. Curr Med Chem 14: 377-386, 2007.
21. Khatib AM, Fallavollita L, Wancewicz EV, Monia BP and Brodt P: Inhibition of hepatic endothelial E-selectin expression by C-raf antisense oligonucleotides blocks colorectal carcinoma liver metastasis. Cancer Res 62: 5393-5398, 2002.
22. Kobayashi K, Matsumoto S, Morishima T, Kawabe T and Okamoto T: Cimetidine inhibits cancer cell adhesion to endothelial cells and prevents metastasis by blocking E-selectin expression. Cancer Res 60: 3978-3984, 2000. (Pubitemid 32204595)
23. Matsumoto S, Imaeda Y, Umemoto S, Kobayashi K, Suzuki H and Okamoto T: Cimetidine increases survival of colorectal cancer patients with high levels of sialyl Lewis-X and sialyl Lewis-A epitope expression on tumour cells. Br J Cancer 86: 161-167, 2002. (Pubitemid 34185140)
24. Hebbar M and Peyrat JP: Significance of soluble endothelial molecule E-selectin in patients with breast cancer. Int J Biol Markers 15: 15-21, 2000. (Pubitemid 30195477)
25. Sheen-Chen SM, Eng HL, Huang CC and Chen WJ: Serum levels of soluble E-selectin in women with breast cancer. Br J Surg 91: 1578-1581, 2004.
26. Tozeren A, Kleinman HK, Grant DS, Morales D, Mercurio AM and Byers SW: E-Selectin-mediated dynamic interactions of breast and colon cancer cells with endothelial cell monolayers. Int J Cancer 60: 426-431, 1995.
27. Kinder M, Chislock E, Bussard KM, Shuman L and Mastro AM: Metastatic breast cancer induces an osteoblast inflammatory response. Exp Cell Res 314: 173-183, 2008. (Pubitemid 350182446)
28. Zhong XY, Kaul S and Bastert G: Evaluation of MUC1 and EGP40 in bone marrow and peripheral blood as a marker for occult breast cancer. Arch Gynecol Obstet 264: 177-181, 2001. (Pubitemid 32105007)
29. Cox GW, Mathieson BJ, Gandino L, Blasi E, Radzioch D and Varesio L: Heterogeneity of hematopoietic cells immortalized by v-myc/v-raf recombinant retrovirus infection of bone marrow or fetal liver. J Natl Cancer Inst 81: 1492-1496, 1989. (Pubitemid 19252402)
30. Eichbaum MHR, Kaltwasser M, Bruckner T, de Rossi TM, Schneeweiss A and Sohn C: Prognostic factors for patients with liver metastases from breast cancer. Breast Cancer Res Tr 96: 53-62, 2006.
31. Cohen AM SB and Friedman MA: Cancer: Principles and Practice of Oncology. Lippincott, Philadelphia, pp. 907-911, 1989.
32. Ueno T, Toi M, Saji H, Muta M, Bando H, Kuroi K, Koike M, Inadera H and Matsushima K: Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res 6: 3282-3289, 2000. (Pubitemid 30637758)
33. Goede V, Brogelli L, Ziche M and Augustin HG: Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. Int J Cancer 82: 765-770, 1999. (Pubitemid 29356979)
34. Saji H, Koike M, Yamori T, Saji S, Seiki M, Matsushima K and Toi M: Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma. Cancer 92: 1085-1091, 2001. (Pubitemid 32861655)
35. Balkwill F and Mantovani A: Inflammation and cancer: Back to Virchow? Lancet 357: 539-545, 2001. (Pubitemid 32173595)
36. Luboshits G, Shina S, Kaplan O, Engelberg S, Nass D, Lifshitz-Mercer B, Chaitchik S, Keydar I and Ben-Baruch A: Elevated expression of the CC chemokine regulated on activation, normal T-cell expressed and secreted (RANTES) in advanced breast carcinoma. Cancer Res 59: 4681-4687, 1999. (Pubitemid 29428976)
37. Niwa Y, Akamatsu H, Niwa H, Sumi H, Ozaki Y and Abe A: Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer. Clin Cancer Res 7: 285-289, 2001. (Pubitemid 32183031)
38. Zhang GJ and Adachi I: Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. Anticancer Res 19: 1427-1432, 1999.
39. Salgado R, Junius S, Benoy I, Van Dam P, Vermeulen P, Van Marck E, Huget P and Dirix LY: Circulating interleukin-6 predicts survival in patients with metastatic breast cancer. Int J Cancer 103: 642-646, 2003. (Pubitemid 36091468)
40. Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, Campion LR, Kaiser EA, Snyder LA and Pollard JW: CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475: 222-225, 2011.
41. Soria G, Yaal-Hahoshen N, Azenshtein E, Shina S, Leider-Trejo L, Ryvo L, Cohen-Hillel E, Shtabsky A, Ehrlich M, Meshel T, Keydar I and Ben-Baruch A: Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions. Cytokine 44: 191-200, 2008.
42. Graves DT and Valente AJ: Monocyte chemotactic proteins from human tumor cells. Biochem Pharmacol 41: 333-337, 1991.
43. McDermott RS, Deneux L, Mosseri V, Vedrenne J, Clough K, Fourquet A, Rodriguez J, Cosset JM, Sastre X, Beuzeboc P, Pouillart P and Scholl SM: Circulating macrophage colony-stimulating factor as a marker of tumour progression. Eur Cytokine Netw 13: 121-127, 2002. (Pubitemid 34535582)
44. Lebrecht A, Grimm C, Lantzsch T, Ludwig E, Hefler L, Ulbrich E and Koelbl H: Monocyte chemoattractant protein-1 serum levels in patients with breast cancer. Tumour Biol 25: 14-17, 2004. (Pubitemid 38822766)
45. Yuan A, Chen JJ, Yao PL and Yang PC: The role of interleukin-8 in cancer cells and microenvironment interaction. Front Biosci 10: 853-865, 2005.
46. Soria G and Ben-Baruch A: The inflammatory chemokines CCL2 and CCL5 in breast cancer. Cancer Lett 267: 271-285, 2008.
47. Fujimoto H, Sangai T, Ishii G, Ikehara A, Nagashima T, Miyazaki M and Ochiai A: Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression. Int J Cancer 125: 1276-1284, 2009.
48. Bingle L, Brown NJ and Lewis CE: The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 196: 254-265, 2002. (Pubitemid 34189413)
49. Pollard JW: Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4: 71-78, 2004.
50. Wyckoff J, Wang WG, Lin EY, Wang YR, Pixley F, Stanley ER, Graf T, Pollard JW, Segall J and Condeelis J: A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 64: 7022-7029, 2004. (Pubitemid 39331012)
51. Lin EY, Gouon-Evans V, Nguyen AV and Pollard JW: The macrophage growth factor CSF-1 in mammary gland development and tumor progression. J Mammary Gland Biol 7: 147-162, 2002. (Pubitemid 38420772)
52. Leek RD and Harris AL: Tumor-associated macrophages in breast cancer. J Mammary Gland Biol Neoplasia 7: 177-189, 2002. (Pubitemid 38420774)
53. Mukhtar RA, Nseyo O, Campbell MJ and Esserman LJ: Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics. Expert Rev Mol Diagn 11: 91-100, 2011.